Key result
Reductions in mean BMI-SDS of 1, 1.2, and 0.7 through lifestyle interventions were significantly associated with mean reductions in SBP, LDL, and TG, respectively (p < 0.05).
Why the study?
The minimum change in BMI-standard deviation score needed to improve lipid profiles and blood pressure in children and adolescents with obesity had not been established.
What minimum change in BMI-standard deviation score (SDS) through lifestyle interventions is required to improve lipid profiles and blood pressure in children and adolescents with obesity?
Meta-Analysis
What minimum change in BMI-standard deviation score (SDS) through lifestyle interventions is required to improve lipid profiles and blood pressure in children and adolescents with obesity?
p-value: p=<0.05
In children and adolescents with obesity, reductions in mean BMI-SDS of >1, >1.2, or >0.7 through lifestyle interventions are required to reliably reduce SBP, LDL, and TG, respectively.
Offers practical benchmarks for lifestyle success in pediatric obesity; extends meta-analyses by quantifying minimal BMI-SDS thresholds for cardiometabolic gains.
Background: Using meta-regression, this article aims at establishing the minimum change in BMI-standard deviation score (SDS) needed to improve lipid profiles and blood pressure in children and adolescents with obesity, to aid future trials and guidelines. Methods: Studies with participants involved in lifestyle interventions, aged 4–19 years, with a diagnosis of obesity according to defined BMI thresholds, were considered for inclusion in a large systematic review. Interventions had to report pre- and post-intervention (or mean change in) BMI-SDS, plus either systolic blood pressure (SBP), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and/or triglycerides (TGs). Random-effects meta-regression quantified the relationship between mean change in BMI-SDS and mean change in cardiovascular outcomes. Results: Seventy-one papers reported various cardiovascular measurements and mean change in BMI-SDS. Fifty-four, 59, 46, and 54 studies were analyzed, reporting a change in SBP, HDL, LDL, and TG, respectively. Reduction in mean BMI-SDS was significantly related to improvements in SBP, LDL, TG, and HDL (p < 0.05); BMI-SDS reductions of 1, 1.2, and 0.7 ensured a mean reduction of SBP, LDL, and TG, respectively, although an equivalent value for HDL improvement was indeterminate. Conclusion: Reductions in mean BMI-SDS of >1, >1.2, or >0.7 are likely to reduce SBP, LDL, and TG, respectively. Further studies are needed to clarify the optimal duration, intensity, and setting for interventions. Consistency is required regarding derived BMI values to facilitate future systematic reviews and meta-analyses.
No takes yet. Share an insight, caveat, or question.
El‐Medany et al. (2020) conducted a meta-analysis in Childhood and adolescent obesity. Reduction in mean BMI-SDS via lifestyle interventions was evaluated on Change in SBP, HDL, LDL, and TG (p=<0.05). Reductions in mean BMI-SDS of 1, 1.2, and 0.7 through lifestyle interventions were significantly associated with mean reductions in SBP, LDL, and TG, respectively (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: